Susanne van Veluw

Susanne van Veluw is a Professor of Translational Vascular Neuroscience at the University of Edinburgh, in the UK. She obtained her PhD in Clinical Neuroscience at the University Medical Center in Utrecht, the Netherlands, after which she moved to Boston, in the US, for her post-doctoral training at Massachusetts General Hospital and Harvard Medical School. While in Boston, she established the Translational Cerebral Amyloid Angiopathy (CAA) Research Lab to study mechanisms of microvascular brain injury. CAA is one of the most common forms of cerebral small vessel disease, associated with haemorrhagic stroke and cognitive impairment. The Translational CAA Research Lab utilizes a complementary range of neuroimaging techniques, including in vivo MRI in patients, ex vivo MRI-guided histopathology in human brain tissue, and in vivo two-photon microscopy in mice to better understand the pathophysiology of microvascular injury in CAA with the goal of uncovering novel treatment targets. Over the summer of 2025, the lab has relocated to the UK, to join the newly established British Heart Foundation – UK Dementia Research Institute – Centre for Vascular Dementia Research.